-
Study aim
-
• Comparison Of The Effect Of Intravenous Magnesium Sulfate With Morphine On Pain Reduction In Patients With Acute Renal Colic In 20 Minutes
• Comparison Of Effect Of Intravenous Magnesium Sulfate With Morphine On Pain Reduction In Patients With Acute Renal Colic In 30 Minutes
• Comparison Of Effect Of Intravenous Magnesium Sulfate With Morphine On Pain Reduction In Patients With Acute Renal Colic In 60 Minutes
• Comparison Of The Effect Of Intravenous Magnesium Sulfate With Morphine On Pain Reduction In Patients With Acute Renal Colic In 120 Minutes
• Comparison Of Effect Of Intravenous Magnesium Sulfate With Morphine On Pain Reduction In Patients With Acute Renal Colic In 180 Minutes
• Determining And Comparing The Effect Of Intravenous Magnesium Sulfate On Pain Reduction In Patients With Acute Renal Colic In Minutes 20, 30, 60, 120, And 180
• Determine And Compare The Effect Of Morphine On Pain Reduction In Patients With Acute Renal Colic In Minutes 20, 30, 60, 120 And 180
• Comparison Of The Effect Of Intravenous Magnesium Sulfate With Morphine On Adverse Reactions In Patients With Acute Renal Colic
• Comparison Of The Effect Of Intravenous Magnesium Sulfate With Morphine On Patients' Satisfaction With Acute Renal Colic
-
Design
-
Initially, Patients With Acute Renal Colic Who Were Eligible For Study And Received Morphine Treatment After 20 Minutes, Also Had A Score Of More Than 6, Were Taken To Participate In A Written And Informed Consent Study, And Then, According To A Random Number Table And Were Randomly Divided Into Two Equal Groups.
-
Settings and conduct
-
A Randomized, Double Blind Clinical Trial Study On Patients With Acute Renal Colic In An Adult Age Group Of 18-60 Years Old Referred To Shahid Beheshti University Of Medical Sciences Hospital In Shohadaye Tajrish Affiliated To Shahid Beheshti University Of Medical Sciences During 2018.
-
Participants/Inclusion and exclusion criteria
-
Inclusion Criteria:
The adult patients with acute renal colic,
Age ranges of 18-60 years old,
The severity of pain between 6 to 10 based on the vas criteria
GCS= 15.
Exclusion Criteria:
Pregnancy Or Suspicion Of Pregnancy, History Of Alcohol Addiction Sensitization To Morphine Or Pain Medication, History Of Mental Illness And Depression And Recent Sedation Or Antipsychotics And Calcium Intake Of Blocker Channel, History Of Drug Dependence, Receiving Analgesic In 6 Recent Illness, Neuromascular Disease And Underlying Bradycardia (Heart Rate Less Than 60), Long Qrs Interval, History Of Heart And Kidney Disease, Liver And Liver Disease, Seizure And History Of Drop In Pressure, Abdominal Pain And Probability Of Peritonitis, Lack Of Consent Of The Patient From Continuing The Study, Unstable Patient With Clinical Condition And Pressure Drop (Systolic Pressure Less Than 90 Or Pressure Foot 20% Of The Base) And A Drop In Heart Rate To Less Than 8, And A Drop In Respiratory Rate To Less Than 60 During The Study.
-
Intervention groups
-
Magnesium Sulfate Group:
Patients With Acute Renal Colic In This Group Received Magnesium Sulfate At A Dose Of 2 G Of 50% Solution At 100 Cc At 15 Minutes.
Morphine Group:
In Patients With Acute Renal Colic, Morphine Was Administered At A Dose Of 0.1 Mg / Kg To 100 Cc At 15 Minutes.
-
Main outcome variables
-
The Primary Outcome Was Pain Reduction And Pain Score Of Less Than 3 Which Was Recorded At 0, 20, 30, 60, 120, 180 And 180 Minutes After Injection In Patients With Acute Renal Colic, Both Groups Of Morphine And Magnesium Sulfate.